Special Report: The Impact of New Iron-Based Phosphate Binders on the Hyperphosphatemia Market
A syndicated report that will provide information on various hyperphosphatemia
market dynamics. It provides insight into practice patterns, attitudes
and perceptions, and current and projected use of phosphate binders.
It will evaluate perceived needs, controversies, and perceived product
advantages and disadvantages.
This report will focus on the impact of new iron-based binders in the U.S.
hyperphosphatemia market.
Related Market Assessment Reports
Report
Chronic Kidney Disease – Current Treatment – Treatment Algorithms: Claims Data Analysis – Chronic Kidney Disease (US)
Chronic kidney disease (CKD) is caused by structural or functional abnormalities in the kidney that impair its ability to filter blood. The CKD drug market primarily comprises antihypertensive…
Report
Chronic Kidney Disease – Geographic Focus: China – Chronic Kidney Disease – China In-Depth (China)
Chronic kidney disease (CKD) is an irreversible condition requiring lifelong management. In China, CKD is notably widespread, particularly among older adults and those with chronic risk factors…
Report
Chronic Kidney Disease – Current Treatment – Current Treatment: Physician Insights – Chronic Kidney Disease (US)
Chronic kidney disease (CKD) is caused by structural or functional abnormalities in the kidney that impair its ability to filter blood. RAAS inhibitors are cornerstones of CKD treatment. SGLT-2…
